Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
Quick Stats
May 20, 202660.4
AI Score
BUY0.46
Volume Ratio
May 12, 2026
Next Earnings
8
+ve Days (30d)
11
-ve Days (30d)
ESPR Stock Summary
Last updated May 20, 2026
ESPR is currently trading at $3.13, positioned above its 200-day moving average of $2.91, indicating a long-term uptrend. The stock has a 52-week range of $0.76 to $4.175.
Technical Analysis: The 50-day moving average stands at $2.56, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 72.124, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.21, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ESPR at 60.4/100 with a BUY recommendation.
ESPR (Esperion Therapeutics, Inc.) Indicators
Last updated May 20, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 72.124 |
| CMF (20) | -0.21 |
| ROC (10) | -0.635 |
| ADX (14) | 38.842 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.203 |
| AROONOSC (14) | 28.571 |
| WILLAMS %R (14) | -62.5 |
| MFI (14) | 71.678 |
ESPR Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ESPR Price vs Max Options Open Interest
ESPR Max Change In Options Open Interest
ESPR Options - Sort by Max open Interest (near term)
21st May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ESPR Daily Out of Money Options - Sort by Max open Interest (near term)
21st May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ESPR Daily In the Money Options - Sort by Max open Interest (near term)
21st May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ESPR Most Active Options by Volume(near term)
21st May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Esperion Therapeutics, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
ESPR Moving Averages Analysis
Esperion Therapeutics, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on May 20, 2026
Esperion Therapeutics, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on May 20, 2026
ESPR (Esperion Therapeutics, Inc.) Simple Moving Averages
Moving Averages are last updated May 20, 2026
| Days | MA |
|---|---|
| 10 | 3.13 |
| 20 | 2.77 |
| 30 | 2.54 |
| 50 | 2.56 |
| 100 | 2.97 |
| 200 | 2.91 |
ESPR Fundamental Analysis
| P/E (Forward) | 4.6382 |
| P/E (Trailing) | 0 |
| Market Cap ($) | 805.8 million |
| Earnings/Share ($) | 0 |
| Net Proft Margin (%) | -0.0178 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.21 |
| EPS Estimate Next Year ($) | 0.292 |
| WallStreet Target Price ($) | 3.19 |
| Most Recent Quarter |
News: $ESPR stock price predicted to reach $27 by April 2026, with potential for sale between $25 and $50 by end of 2026. Speculation of manipulation around $2.50 price point in recent offering. Analysts believe company may see increase in positive news and stock price in coming months. Concerns raised about potential influence of major shareholders on stock price. Company expected to become cash flow positive with growth in sales and upcoming milestones.
Updated 2025-10-08 03:00:02